Clinical Trials Browser

Advanced Non-small Cell Lung Cancer × tislelizumab × 90 days × Clear all

NCT06868732 2026-03-30

Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC

Phase 1 Recruiting

Advanced Non-small Cell Lung Cancer